Yahoo · Sep 1, 2026
Mid-cap biotechs join Trump’s latest round of drug pricing deals
Focused on Medicaid, the new pacts now involve more than just large pharmaceutical companies, but still aren’t expected to meaningfully impact drugmaker profits.
AL
OTC · ALPMY
Astellas Pharma Inc.
Healthcare · Drug Manufacturers - General
$15.23
Up+$0.46 (+3.09%)
Updated Sep 17, 2026, 2:15 PM
SID Score
6.5/10
Composite research score
Smart Money
46/100
Neutral
- Market cap
- 29.58B
- P/E ratio
- 14.43
- Dividend yield
- 3.17%
- 52-week range
- — – —
- Volume
- 107
- Avg. volume
- 127.41K
Price performance
ALPMY price history
1M range · 0 trading sessions · Daily adjusted prices
ALPMY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest ALPMY news
The latest Smart Investors Daily articles mentioning ALPMY.
Stock researchCompany · Overview
ALPMY research
Overview
Company profile and research snapshot.
Company profile
ASTELLAS PHARMA UNSP/ADR
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Yahoo · Sep 1, 2026
Trump lines up MFN deals with nine mid-size pharmas on drug pricing push
These deals will require the companies to provide MFN prices to state Medicaid programmes nationally.
Yahoo · Sep 1, 2026
Trump's Pharma Pricing Deal Expands as Healthcare Stocks Keep Climbing
Trump expanded his drug pricing deal to 26 pharma firms as UBS says healthcare stocks still have room to climb.
Yahoo · Aug 31, 2026
Astellas enters voluntary agreement with U.S. government supporting affordable access to medicines
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that it has reached an agreement with the U.S. government that reflects our commitment to patient access, affordability and innovation, while reinforcing Astellas' longstanding commitment to the U.S. healthcare system.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
